June 27, 2025 - 07:05

Passengers traveling through MSP Airport can now experience a more efficient customs process thanks to the introduction of Enhanced Passenger Processing technology. Instead of the traditional method of approaching a customs officer at a desk, travelers will use a touchscreen device approximately the size of a tablet. This new system aims to streamline the customs experience, allowing for quicker processing and reduced wait times.
The touchscreen devices enable passengers to input their information directly, which is then processed rapidly. This innovation is expected to alleviate congestion during peak travel times, making the overall experience more pleasant for travelers. Airport officials believe that this technology will not only enhance the efficiency of customs operations but also improve passenger satisfaction.
As more airports look to modernize their facilities, MSP's commitment to adopting cutting-edge technology reflects a broader trend in the aviation industry aimed at enhancing the travel experience. Passengers can look forward to a smoother journey as these advancements take effect.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...